Until the product launches and there's some evidence of sales,...

Until the product launches and there's some evidence of sales, there's nothing to really give the price any sort of momentum.

Now that the company has raised, they should be covered financially for the next twelve months so they've got that long to start making an impact.

One speculation: if the product launches, supply lines work OK and there's some early demand, maybe the price will rise due to on the ground experience. (eg if you're a patient who uses it or a doctor who tries it out). So it will be interesting to see what happens to the price in Q2.

I'll be a bit worried if the launch gets delayed beyond Q2 though.